[Featured Stock] Three Billion Soars Over 20%... Surpasses 7,000 Won Intraday
The stock price of Three Billion, an AI-based genetic disease diagnostic testing company, is showing a strong gain of over 20%.
![[Featured Stock] Three Billion Soars Over 20%... Surpasses 7,000 Won Intraday](http://www.asiae.co.kr/news/img_view.htm?img=2024072208164559128_1721603806.jpg)
As of 2:12 PM on the 17th, just before the market close, Three Billion's stock is trading at 6,970 KRW per share, up 22.93% compared to the previous trading day. During the session, the price briefly surpassed 7,000 KRW per share.
This surge is attributed to the news that the company signed a memorandum of understanding (MOU) for genetic testing cooperation with Korea AstraZeneca before the market opened, which triggered buying interest.
Hot Picks Today
"Should Get at Least 45 Million Won Salary" "Can't Give Up on Large Companies"... Young People Say There Are No Places to Apply
- Unemployment Benefits to Drop from 1.98 Million to 1.76 Million Won per Month...Employment Insurance Premium Rate to Rise from 1.8% to 2%
- Packed Crowds with “It’s So Cheap!”... Japan Travel by UK Millennials & Gen Z Surges 25% in a Year
- "Only One Restroom Break per Semester During Class"…Controversy Over Chinese High School Regulations
- When "Cutting Down Reserved Tents" Brings Relief: Local Governments Take Action Against Escalating 'Reserved Tent' Problem
Through this collaboration, Three Billion and AstraZeneca plan to establish a genetic testing system capable of completing diagnosis within two weeks for patients with atypical hemolytic uremic syndrome (aHUS), a rare disease.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
